Table 5.
Risk factors of secondary CNV subsequent to development of CSC with multivariate regression analysis.
| Parameters | OR (95% CI) | P-value* |
|---|---|---|
| Age | 0.92 (0.83–1.02) | 0.09 |
| Systemic hypertension | 7.72 (1.26–47.36) | 0.03 |
| Macula edema | 0.48 (0.005–44.55) | 0.75 |
| Double layer sign | 12.32 (2.04–74.4) | 0.006 |
| Ellipsoid zone disruption | 2.75 (0.47–16.14) | 0.26 |
| Hyperfluorescent spots-perifoveal area | 0.08 (0.02–0.42) | 0.003 |
| Leaking points | 2.02 (0.60–6.82) | 0.26 |
| RPE changes | 9.00 (1.46–55.62) | 0.02 |
RPE = retinal pigment epithelium; CI = confidence interval; OR = odds ratio.
*Values in bold are statistically significant results.